Lynne Marie Sullivan serves as Executive at Unity Biotechnology, Inc., where they oversee executive responsibilities. Since joining the company, Lynne Marie Sullivan has executed 7 insider transactions totaling $50.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 2, 2024 involved selling 139 shares valued at $213.
Lynne Marie Sullivan currently holds 56,061 shares of Unity Biotechnology, Inc. (UBX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lynne Marie Sullivan has been a net buyer of UBX stock. They have purchased $50.0K and sold $666 worth of shares.
Lynne Marie Sullivan's most recent insider trade was on Aug 2, 2024, when they sold 139 shares at $1.53 per share.
Get notified when new Form 4 filings are submitted
| $1.40 |
| Discretionary |
| May 15, 2022 | UBX | $6.4K | Other | 925 | $6.89 | Discretionary |
| Feb 9, 2022 | UBX | $0 | Award | 50,000 | $N/A | Discretionary |
| Jul 28, 2021 | PHGE | $50.0K | Purchase | 12,500 | $4.00 | Discretionary |
| Jun 24, 2021 | UBX | $0 | Award | 30,833 | $N/A | Discretionary |
| Sep 13, 2020 | UBX | $0 | Award | 240,000 | $N/A | Discretionary |